The relation between negative symptoms and reward alterations before and after antipsychotic treatment in first episode patients with schizophrenia

被引：0
|
作者：
Nielsen, M. O. [1 ]
Wulff, S. [2 ]
Rostrup, E. [3 ]
Glenthoj, B. [1 ]
机构：
[1] Copenhagen Unviers Hosp, Fac Hlth & Med Sci, Ctr Clin Intervent & Neuropsychiat Schizophrenia, CINS, Glostrup, Denmark
[2] Mental Hlth Ctr Glostrup, Ctr Clin Intervent & Neuropsychiat Schizophrenia, CINS, Glostrup, Denmark
[3] Univ Hosp Glostrup, Funct Imaging Unit, Glostrup, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
D O I：
10.1016/S0924-977X(17)31716-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.012
引用
收藏
页码：S973 / S974
页数：2
相关论文
共 50 条
  • [31] ALTERED PATTERNS OF REWARD ACTIVATION IN A LARGE COHORT OF ANTIPSYCHOTIC NAIVE FIRST EPISODE SCHIZOPHRENIA PATIENTS
    Nielsen, Mette Odegaard
    Rostrup, Egill
    Wullf, Sanne
    Norbak-Emig, Henrik
    Raghava, Jayachandra
    Glenthoj, Birte
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S50 - S50
  • [32] Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment
    Zeng, Botao
    Ardekani, Babak A.
    Tang, Yingying
    Zhang, Tianhong
    Zhao, Shanshan
    Cui, Huiru
    Fan, Xiaoduo
    Zhuo, Kaiming
    Li, Chunbo
    Xu, Yifeng
    Goff, Donald C.
    Wang, Jijun
    SCHIZOPHRENIA RESEARCH, 2016, 172 (1-3) : 1 - 8
  • [33] Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine
    Aggernaes, Bodil
    Glenthoj, Birte Y.
    Ebdrup, Bjorn H.
    Rasmussen, Hans
    Lublin, Henrik
    Oranje, Bob
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (10): : 1383 - 1395
  • [34] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Liisa Leppik
    Madis Parksepp
    Sven Janno
    Kati Koido
    Liina Haring
    Eero Vasar
    Mihkel Zilmer
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 59 - 70
  • [35] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Leppik, Liisa
    Parksepp, Madis
    Janno, Sven
    Koido, Kati
    Haring, Liina
    Vasar, Eero
    Zilmer, Mihkel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (01) : 59 - 70
  • [36] Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis
    Berger, Maximus
    Juster, Robert-Paul
    Westphal, Sabine
    Amminger, G. Paul
    Bogerts, Bernhard
    Schiltz, Kolja
    Bahn, Sabine
    Steiner, Johann
    Sarnyai, Zoltan
    PSYCHONEUROENDOCRINOLOGY, 2018, 90 : 35 - 42
  • [37] The relationship between alterations in metabolite levels in the DLPFC and clinical symptoms of patients with first-episode schizophrenia
    Huang, M.
    Guo, W.
    Lu, S.
    Xu, Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S885 - S885
  • [38] Alterations of the Brain Reward System in Antipsychotic Naive Schizophrenia Patients
    Nielsen, Mette Odegaard
    Rostrup, Egill
    Wulff, Sanne
    Bak, Nikolaj
    Lublin, Henrik
    Kapur, Shitij
    Glenthoj, Birte
    BIOLOGICAL PSYCHIATRY, 2012, 71 (10) : 898 - 905
  • [39] Patterns of positive and negative symptoms in first episode schizophrenia
    VazquezBarquero, JL
    Lastra, I
    Nunez, MJC
    Castanedo, SH
    Dunn, G
    BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 (06) : 693 - 701
  • [40] A longitudinal study investigating cognitive performance in first-episode patients before and after antipsychotic treatment
    Hilti, C.
    Orosz, A.
    Thomann, K.
    Delko, T.
    Ludewig, S.
    Vollenweider, F.
    Feldon, J.
    Cattapan-Ludewig, K.
    NEUROPSYCHOBIOLOGY, 2006, 54 (01) : 2 - 2
12345